This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Merck Canada Inc., Merck Sharp + Dohme Corp.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 40 
1 out of 2,405 
Years Active: 2014
Title: The Innovations of Basil Avery Ince
Introduction
Basil Avery Ince is a notable inventor based in Westfield, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of bone resorption inhibition. His work has implications for treating conditions related to bone health.
Latest Patents
Ince holds a patent for a composition aimed at inhibiting cathepsin K. This invention relates to a method of inhibiting bone resorption in mammals through an oral pharmaceutical composition. The composition includes a cathepsin K inhibitor or a pharmaceutically acceptable salt thereof, administered on a continuous schedule with various dosage intervals.
Career Highlights
Throughout his career, Ince has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Merck Canada Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for health-related challenges.
Collaborations
Ince has collaborated with notable professionals in his field, including Anastasia G Daifotis and Selwyn Aubrey Stoch. These collaborations have likely enriched his work and expanded the impact of his inventions.
Conclusion
Basil Avery Ince's contributions to pharmaceutical innovation, particularly in bone health, highlight his role as a significant inventor. His patent for inhibiting cathepsin K showcases his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile